<DOC>
	<DOCNO>NCT01131910</DOCNO>
	<brief_summary>The investigator intend check whether efficacy TBE-vaccine substantially deteriorate patient rheumatoid arthritis treat drug suppress immune system . The investigator aim detect difference least 10 % compare healthy individual ( historical control ) protection analyse serology . If investigator detect difference , investigator continue explore whether protection achieve additional dos</brief_summary>
	<brief_title>TBE-vaccine Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Rheumatoid arthritis treat methotrexate and/or TNFalfa block drug Interest vaccinate Written consent Age 18 year Previous TBEinfection Previous Vaccination TBE Pregnancy Breast feeding Treatment rituximab last 9 month Inability follow study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>TBE-vaccine</keyword>
	<keyword>Immunosuppression</keyword>
</DOC>